Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Serono second quarter results

Serono (SWX:SEO; SRA) reported second quarter earnings per ADS of $0.17, up 13% over $0.15 in the second quarter of

Read the full 208 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE